Literature DB >> 31415341

Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis: A Cohort Study.

Pooja A Lagisetty1,2,3, Lewei A Lin1,3,4, Dara Ganoczy1, Rebecca L Haffajee3,5,6, Theodore J Iwashyna1,2,3, Amy S B Bohnert1,3,6.   

Abstract

BACKGROUND: Any opioid-related hospitalization is an indicator of opioid-related harm and should ideally trigger carefully monitored decreases in opioid prescribing after inpatient stays in many, if not most, cases. However, past studies on opioid prescribing after hospitalizations have largely been limited to overdose related visits. It is unclear whether prescribing is different for other opioid-related indications such as opioid dependence and abuse and how that may compare with hospitalizations for overdose.
OBJECTIVE: To examine opioid-prescribing patterns before and after opioid-related hospitalizations for all opioid-related indications, not limited to overdose. RESEARCH
DESIGN: Retrospective cohort analysis of Veterans Health Administration (VHA) administrative claims from 2011 to 2014.
SUBJECTS: VHA patients who were hospitalized between fiscal years 2011 and 2014 and had at least 1 prescription opioid medication filled through the VHA pharmacy before their hospitalization. MEASURES: Opioid dispensing trajectories after hospitalization by opioid-related indication (ie, opioid dependence and/or abuse vs. overdose) compared with prescribing patterns for non-opioid-related hospitalizations.
RESULTS: Overall, opioid dosage dropped significantly (66% for dependence/abuse, 42% for overdose, and 3% for nonopioid diagnoses; P<0.001) across all 3 categories when comparing dose 57-63 days after admission to 57-63 days before hospitalization. However, 47% of the patients remained on the same dose or increased their opioid dose at 60 days after an opioid-related hospitalization. After adjusting for covariates, patients with a primary diagnosis of dependence/abuse had higher odds of having their dose discontinued compared with those with overdose: odds ratio (OR) 2.17 (1.19-3.96). Patients with admissions for opioid dependence and/or abuse had a statistically significant higher prevalence of depression, posttraumatic stress disorder, anxiety, and substance use disorders compared with those with an opioid overdose hospitalization.
CONCLUSIONS: Opioid prescribing and patient risk factors before and after opioid-related hospitalizations vary by indication for hospitalization. To reduce costs and morbidity associated with opioid-related hospitalizations, opioid deintensification efforts need to be tailored to indication for hospitalization.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31415341      PMCID: PMC6742521          DOI: 10.1097/MLR.0000000000001182

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  27 in total

1.  Prescriptions Filled Following an Opioid-Related Hospitalization.

Authors:  Sarah Naeger; Mir M Ali; Ryan Mutter; Tami L Mark; Lauren Hughey
Journal:  Psychiatr Serv       Date:  2016-06-01       Impact factor: 3.084

2.  Prevalence and characteristics of hospitalized adults on chronic opioid therapy.

Authors:  Hilary J Mosher; Lan Jiang; Mary S Vaughan Sarrazin; Peter Cram; Peter J Kaboli; Mark W Vander Weg
Journal:  J Hosp Med       Date:  2013-12-06       Impact factor: 2.960

3.  Trends in Prescription Pain Medication Use by Race/Ethnicity Among US Adults With Noncancer Pain, 2000-2015.

Authors:  Jordan M Harrison; Pooja Lagisetty; Brian D Sites; Cui Guo; Matthew A Davis
Journal:  Am J Public Health       Date:  2018-04-19       Impact factor: 9.308

4.  Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department.

Authors:  Christopher Rowe; Eric Vittinghoff; Glenn-Milo Santos; Emily Behar; Caitlin Turner; Phillip O Coffin
Journal:  Acad Emerg Med       Date:  2017-03-17       Impact factor: 3.451

5.  Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients.

Authors:  Julie R Gaither; Kirsha Gordon; Stephen Crystal; E Jennifer Edelman; Robert D Kerns; Amy C Justice; David A Fiellin; William C Becker
Journal:  Drug Alcohol Depend       Date:  2018-08-06       Impact factor: 4.492

6.  Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder.

Authors:  Sarah Naeger; Ryan Mutter; Mir M Ali; Tami Mark; Lauren Hughey
Journal:  J Subst Abuse Treat       Date:  2016-07-18

7.  Drug overdose surveillance using hospital discharge data.

Authors:  Svetla Slavova; Terry L Bunn; Jeffery Talbert
Journal:  Public Health Rep       Date:  2014 Sep-Oct       Impact factor: 2.792

8.  A Detailed Exploration Into the Association of Prescribed Opioid Dosage and Overdose Deaths Among Patients With Chronic Pain.

Authors:  Amy S B Bohnert; Joseph E Logan; Dara Ganoczy; Deborah Dowell
Journal:  Med Care       Date:  2016-05       Impact factor: 2.983

Review 9.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

10.  Racial-Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse.

Authors:  Astha Singhal; Yu-Yu Tien; Renee Y Hsia
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

View more
  2 in total

1.  Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse.

Authors:  Pooja Lagisetty; Claire Garpestad; Angela Larkin; Colin Macleod; Derek Antoku; Stephanie Slat; Jennifer Thomas; Victoria Powell; Amy S B Bohnert; Lewei A Lin
Journal:  Drug Alcohol Depend       Date:  2021-02-13       Impact factor: 4.492

Review 2.  Mental disorder and opioid overdose: a systematic review.

Authors:  Jenna van Draanen; Christie Tsang; Sanjana Mitra; Vanessa Phuong; Arata Murakami; Mohammad Karamouzian; Lindsey Richardson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-11-18       Impact factor: 4.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.